Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema
This study has been completed.
Study NCT00369486 Information provided by Diabetic Retinopathy Clinical Research Network
First Received on August 25, 2006. Last Updated on May 12, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Macular Edema
Additional conditions recognized in this trial
Edema
Macular Edema
More general conditions related to this trial
Eye Diseases
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Signs and Symptoms
Interventions listed in this trial
Focal laser photocoagulation
40mg triamcinolone
20mg triamcinolone
40mg triamcinolone + laser
20mg triamcinolone + laser
Additional drug interventions recognized in this trial
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
More general drug interventions related to this trial
Anti-Inflammatory Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Diabetic Retinopathy Clinical Research Network
National Eye Institute (NEI)
Back to top of Main Content
